Medicare Enrolled

Dr. Asif Rafi, M.D.

Allergy & Immunology · Los Angeles, CA
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Speaking/Promotional
11500 WEST OLYMPIC BLVD, Los Angeles, CA 90064
3103931550
In practice since 2006 (19 years)
NPI: 1265549455 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Rafi from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Rafi? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Rafi

Dr. Asif Rafi is an allergy & immunology specialist in Los Angeles, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Rafi performed 43,088 Medicare services across 571 unique beneficiaries.

Between the years covered by Open Payments, Dr. Rafi received a total of $49,416 from 45 pharmaceutical and/or device companies across 687 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in allergy & immunology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Rafi is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 2% volume in CA $49,416 industry payments

Medicare Practice Summary

Medicare Utilization ↗
43,088
Medicare services
Top 2% in CA for allergy & immunology
571
Unique beneficiaries
$29
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~2,268 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Omalizumab injection (Xolair) for asthma/allergy 38,461 $30 $50
Drug injection, under skin or into muscle
A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle.
1,346 $12 $80
Allergy skin test
A diagnostic test performed to identify specific allergies by applying or introducing allergenic extracts to the body. The procedure measures the patient's immune response to various potential allergens.
1,223 $4 $12
Airflow rate measurement test
A test that measures the rate of airflow. This procedure assesses how quickly air moves.
489 $34 $75
Middle ear function test
A diagnostic test used to evaluate how well the middle ear is functioning.
452 $14 $30
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
338 $103 $200
Nitric oxide gas level test
A test that measures the level of nitric oxide gas in the body.
298 $17 $30
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
218 $74 $150
Allergy injection therapy, multiple injections
A professional service involving the administration of multiple allergen injections.
127 $10 $40
Spirometry test before and after medication
A test that measures the amount of air you can exhale and the speed of your breathing before and after taking a medication.
33 $35 $95
Inhalation treatment for acute airway obstruction, first hour
This procedure involves administering inhaled medication to treat acute airway obstruction during the first hour of treatment.
29 $56 $120
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
22 $137 $275
Online digital E/M service, established patient, 21+ minutes
An online digital evaluation and management service for an established patient. This service requires a total time of 21 or more minutes over a period of up to 7 days.
18 $31 $100
Quadrivalent influenza vaccine, preservative-free
A flu shot containing four strains of the influenza virus, formulated without preservatives, administered in a 0.5 ml dose.
17 $22 $50
Flu vaccine administration
This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient.
17 $29 $30
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$49,416
Total received (2018-2024)
Avg $7,059/year across 7 years
Top 12% in CA for allergy & immunology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
45
Companies
687
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$25,618 (51.8%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$15,360 (31.1%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$8,438 (17.1%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$17,593
2023
$9,393
2022
$2,658
2021
$2,824
2020
$1,412
2019
$3,683
2018
$11,852

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$15,694
Regeneron Healthcare Solutions, Inc.
$441
GENZYME CORPORATION
$258
GlaxoSmithKline, LLC.
$226
Genentech USA, Inc.
$223
Novartis Pharmaceuticals Corporation
$148
Takeda Pharmaceuticals U.S.A., Inc.
$106
Genentech, Inc.
$97
PFIZER INC.
$97
Hikma Pharmaceuticals USA
$67
Grifols USA, LLC
$66
Optinose US, Inc.
$41
Phadia US Inc.
$32
Octapharma USA, Inc.
$30
ABBVIE INC.
$28
Incyte Corporation
$21
Amgen Inc.
$18
Top 3 companies account for 93.2% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$24,469
GENZYME CORPORATION
$9,495
Novartis Pharmaceuticals Corporation
$4,252
Regeneron Healthcare Solutions, Inc.
$2,924
GlaxoSmithKline, LLC.
$1,687
Genentech USA, Inc.
$856
PFIZER INC.
$684
Amgen Inc.
$526
Takeda Pharmaceuticals U.S.A., Inc.
$479
Octapharma USA, Inc.
$420
Grifols USA, LLC
$335
Optinose US, Inc.
$291
Genentech, Inc.
$245
Bio Products Laboratory USA, Inc.
$244
Shire North American Group Inc
$228
Mylan Specialty L.P.
$199
kaleo, Inc.
$190
OptiNose US, Inc.
$189
Teva Pharmaceuticals USA, Inc.
$147
CSL Behring
$147
ABBVIE INC.
$114
Biohaven Pharmaceutical Holding Company Ltd.
$109
BioCryst US Sales Co., LLC
$105
Hikma Pharmaceuticals USA
$91
Sunovion Pharmaceuticals Inc.
$91
Regeneron Pharmaceuticals, Inc.
$85
Phadia US Inc.
$84
Covis Pharma GmBH
$77
Boehringer Ingelheim Pharmaceuticals, Inc.
$76
Allergan, Inc.
$69
Kaleo, Inc.
$69
Biohaven Pharmaceuticals, Inc.
$62
AbbVie Inc.
$50
Incyte Corporation
$47
Circassia Pharmaceuticals Inc
$43
LEO Pharma Inc.
$40
Blueprint Medicines Corporation
$30
SANOFI-AVENTIS U.S. LLC
$25
TerSera Therapeutics LLC
$24
ALK-Abello, Inc
$22
Horizon Therapeutics plc
$21
Advanced Respiratory, Inc
$21
Eyevance Pharmaceuticals LLC
$20
Seqirus USA Inc
$19
Baxter Healthcare
$18
Top 3 companies account for 77.3% of all-time payments
Associated products mentioned in payments ›
ACTIMMUNE · ADBRY · AIMOVIG · AIRSUPRA · AJOVY · ALVESCO · ANORO · AREXVY · AUVI-Q · Aimovig · AirDuo Digihaler · Auvi-Q · BEVESPI AEROSPHERE · BREO · BREZTRI · BREZTRI AEROSPHERE · BROVANA · CIBINQO · CINQAIR · CUTAQUIG · CUVITRU · DUPIXENT · DUPIXENT DUPILUMAB INJECTION · Dymista · ENSTILAR · EOHILIA · EUCRISA · FARXIGA · FASENRA · FLUCELVAX QUADRIVALENT · Gammaplex · Gamunex-C · Grastek · HYQVIA · Haegarda · Hillrom - Vest System Model 105 Home Care · Hizentra · ImmunoCAP · LONHALA MAGNAIR · NIOX VERO · NUCALA · NURTEC ODT · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OPZELURA · ORLADEYO · PANZYGA · PREVNAR 20 · ProAir Digihaler · QVAR · Quzyttir · RINVOQ · Ryaltris · SHINGRIX · SKYRIZI · SPIRIVA RESPIMAT · STIOLTO RESPIMAT · SYMBICORT · TAKHZYRO · TEZSPIRE · TRELEGY ELLIPTA · TUDORZA PRESSAIR · The Vest System Model 105 Home Care · UBRELVY · Utibron · XOLAIR · Xembify · Xhance · Xolair · YUPELRI · Yupelri · Zerviate
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (52%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in allergy & immunology and does not inherently indicate bias, but patients may wish to be aware.

Looking for an allergy & immunology specialist in Los Angeles?
Compare allergy & immunologists in the Los Angeles area by procedure volume, costs, and industry payment transparency.
Browse allergy & immunologists nearby

Geographic Context

Allergy & immunologists within 10 mi
72
Per 100K population
0.7
County median income
$87,760
Nearest hospital
KAISER FOUNDATION HOSPITAL - WEST LA
1.6 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Rafi is a mixed practice specialist, with above-average Medicare volume (top 2% in CA), with speaking/promotional industry engagement in the top 12% of CA peers, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Rafi experienced with omalizumab injection (xolair) for asthma/allergy?
Based on Medicare claims data, Dr. Rafi performed 38,461 omalizumab injection (xolair) for asthma/allergy services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Rafi receive payments from pharmaceutical companies?
Yes. Dr. Rafi received a total of $49,416 from 45 companies across 687 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Rafi's costs compare to other allergy & immunologists in Los Angeles?
Dr. Rafi's average Medicare payment per service is $29. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Rafi) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →